New Preliminary Findings on Potential Response Indicator of Rakuten Medical’s Alluminox Treatment from Phase 2 Window of Opportunity Study at SNMMI 2023

– 18F-FDG PET/CT imaging 1 day after Alluminox treatment with ASP-1929 may serve as a potential indicator of treatment response – The oral presentation was given by Dr. Lindenberg of NCI, NIH, which is collaborating with Rakuten Medical to conduct ASP-1929-103, the Company’s very first…